| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |